Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH)
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled, double-blind, phase II clinical study to evaluate the efficacy
and safety of Udenafil in patient with Pulmonary Arterial Hypertension(PAH).